Skip to main content
. Author manuscript; available in PMC: 2023 May 14.
Published in final edited form as: HPB (Oxford). 2019 Jun 21;22(2):215–223. doi: 10.1016/j.hpb.2019.05.020

Table 1.

Clinical and pathological characteristics of the study cohort

Variables Value
Age (years) 58 (47–66)
Sex
 Female 496 (48.6%)
 Male 524 (51.4%)
Functional status
 Nonfunctional 838 (82.2%)
 Functional 164 (16.1%)
Genetic syndrome
 None 895 (87.7%)
 MEN-1 85 (8.3%)
 VHL 10 (1.0%)
Symptomatic
 N0 442 (43.3%)
 Yes 558 (54.7%)
Primary location
 Head 284 (27.8%)
 Uncinated 44 (4.3%)
 Neck/body 234 (22.9%)
 Tail 401 (39.3%)
 Multiple 51 (5.0%)
Multiple tumor nodules
 Single 909 (89.1%)
 Multiple 106 (10.4%)
Tumor size (cm) 2.1 (1.4–3.5)
Lymph nodes metastasis
 No 623 (61.1%)
 Yes 235 (23.0%)
Ki-67 category
 <3% 412 (40.4%)
 3–20% 249 (24.4%)
 >20% 26 (2.5%)
Tumor differentiation
 Well 781 (76.6%)
 Moderately 89 (8.7%)
 Poorly 20 (2.0%)
Surgical technique
 Open 778 (76.3%)
 Laparoscopic/robotic 239 (23.4%)
Type of resection
 Enucleation 107 (10.5%)
 Classic PD 129 (12.6%)
 Pylorus preserving PD 159 (15.6%)
 Central pancreatectomy 32 (3.1%)
 Distal pancreatectomy 576 (56.5%)
 Total pancreatectomy 17 (1.7%)
Perineural invasion 169 (16.6%)
Major vascular resection 49 (4.8%)
Lymphadenectomy 858 (84.1%)
Number of lymph node retrieved 10 (5–16)
Operation time (min) 235 (185–315)
Blood loss (ml) 200 (100–400)
Margin status
 R0 866 (84.9%)
 R1 154 (15.1%)
Postoperative morbidity 544 (53.3%)
Severe complication (III–V) 225 (22.1%)
Adjuvant chemotherapy 25 (2.5%)